734-936-8000 - Service Desk | Request Support

FODMAP Module 04: Assessing indications & Contraindications for the low FODMAP diet

To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.

Step Status
Evaluation
Release Date: Wed, 11/17/21
Termination Date: Thu, 10/31/24
Credits: 1
Description:

Link to Educational Material

Module 4:

Assessing indications & Contraindications for the low FODMAP diet

Dr Stine Störsrud, RD, PhD

  • Identify patients who are suitable candidates for the low FODMAP diet.
  • Examine medical assessment has eliminated conditions with overlapping symptoms with IBS such as cancers, IBD or Coeliac disease.
  • Identify “red flags” which contraindicate management through the low FODMAP diet, such as those with a history of eating disorders.
  • Conduct adequate symptom and diet assessment including types of food, quantity and timing of meals and symptoms.
Target Audience: This activity is appropriate for Medical Students, Nurse Practitioners, Nurses, Other Healthcare Professionals, Physicians in the fields of Gastroenterology, Other Healthcare Professions.
Accreditation and Credit Designation:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Michigan Medical School and GI Institute. The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Michigan Medical School designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Info: Bibliographic Resources

Palsson O, Whitehead W, Tornblom H, et al. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom
Gastroenterology 2020;158:1262–1273.

Chey WD, Eswaran S, Kurlander J. Management of Irritable Bowel Syndrome. JAMA 2015; 313(9):949-958.

Agarwal N, Spiegel B. . The Effect of Irritable Bowel Syndrome on Health-Related Quality of Life and Health Care Expenditures. Gastroenterol Clin North Am. 2011;40(1):11-19.

Gralnek IM, Hayes RD, Kilbourne A, et al. The impact of IBS on health-related quality of life. GASTROENTEROL 2000;119:654–660.

Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?
Gastroenterology. 2002;122:1140-1156.

Levy RL, Olden KW, Naliboff B, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology. 2006;130:1447-1458.

Credits available:

AMA PRA Category 1: 1.00
Participation: 1.00